Peter Vanderslice

Peter Vanderslice

Company: 7 Hills Pharma

Job title: Co-Founder

Seminars:

Panel Discussion: Genesis of 7 Hills Pharma & Translation of Integrin Agonist into the Clinic 9:40 am

Translating Biology into Clinic – potential clinical indications (augmenting infectious disease vaccination and solid tumor immunity) Why have there been limited development of integrin agonists? Safety and efficacy? The game changer? What data gives us the confidence of this approach?Read more

day: Day One

Roundtable Discussion:Specific v Pan Inhibition of Integrins 12:00 pm

Integrin targets are very widely expressed Define specificity early on to ensure off-target effects are minimized down-stream Assess the advantages and disadvantages of specific versus pan inhibition of integrins Discuss with your peers in this roundtable discussion, grouped by disease indication Down stream adaptor proteinsRead more

day: Day One

Agonist Mechanisms to Address the Treatment Paradigm 8:40 am

Most integrin-targeted candidates use antagonist mechanisms Explore the potential of positive regulation on integrins Assess the benefits of this compared to antagonistsRead more

day: Day One

© Copyright 2022 Hanson Wade | Design and site by Event Engine | Hanson Wade Limited is registered in England & Wales, number 06752216.
Registered Office: Suite A, 6 Honduras Street, London EC1Y 0TH.